AI In Oncology Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of AI In Oncology Market

1.1. Definition and Scope

1.1.1. Definition of AI In Oncology

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global AI In Oncology Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. AI In Oncology Market By Component

1.2.3. AI In Oncology Market By Cancer Type

1.2.4. AI In Oncology Market By Treatment Type

1.2.5. AI In Oncology Market By End-Users

1.2.6. AI In Oncology Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of AI In Oncology Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for AI In Oncology Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. AI In Oncology Market By Component

5.1. Introduction

5.2. AI In Oncology Revenue By Component

5.2.1. AI In Oncology Revenue (USD Billion) and Forecast, By Component, 2020-2032

5.2.2. Hardware

5.2.2.1. Hardware Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Software Solutions

5.2.3.1. Software Solutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Services

5.2.4.1. Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. AI In Oncology Market By Cancer Type

6.1. Introduction

6.2. AI In Oncology Revenue By Cancer Type

6.2.1. AI In Oncology Revenue (USD Billion) and Forecast, By Cancer Type, 2020-2032

6.2.2. Breast Cancer

6.2.2.1. Breast Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Prostate Cancer

6.2.3.1. Prostate Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Lung Cancer

6.2.4.1. Lung Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Brain Tumor

6.2.5.1. Brain Tumor Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.6. Colorectal Cancer

6.2.6.1. Colorectal Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.7. Others

6.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. AI In Oncology Market By Treatment Type

7.1. Introduction

7.2. AI In Oncology Revenue By Treatment Type

7.2.1. AI In Oncology Revenue (USD Billion) and Forecast, By Treatment Type, 2020-2032

7.2.2. Chemotherapy

7.2.2.1. Chemotherapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Immunotherapy

7.2.3.1. Immunotherapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Radiotherapy

7.2.4.1. Radiotherapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Others

7.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. AI In Oncology Market By End-Users

8.1. Introduction

8.2. AI In Oncology Revenue By End-Users

8.2.1. AI In Oncology Revenue (USD Billion) and Forecast, By End-Users, 2020-2032

8.2.2. Hospitals

8.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. Research Institutes

8.2.3.1. Research Institutes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.4. Pharmaceutical Companies

8.2.4.1. Pharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.5. Diagnostic Centers

8.2.5.1. Diagnostic Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.6. Others

8.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 9. North America AI In Oncology Market By Country 

9.1. North America AI In Oncology Market Overview

9.2. U.S.

9.2.1. U.S. AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

9.2.2. U.S. AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

9.2.3. U.S. AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

9.2.4. U.S. AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

9.3. Canada

9.3.1. Canada AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

9.3.2. Canada AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

9.3.3. Canada AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

9.3.4. Canada AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe AI In Oncology Market By Country

10.1. Europe AI In Oncology Market Overview

10.2. U.K.

10.2.1. U.K. AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

10.2.2. U.K. AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

10.2.3. U.K. AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

10.2.4. U.K. AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

10.3. Germany

10.3.1. Germany AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

10.3.2. Germany AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

10.3.3. Germany AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

10.3.4. Germany AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

10.4. France

10.4.1. France AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

10.4.2. France AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

10.4.3. France AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

10.4.4. France AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

10.5. Spain

10.5.1. Spain AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

10.5.2. Spain AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

10.5.3. Spain AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

10.5.4. Spain AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

10.6.2. Rest of Europe AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

10.6.3. Rest of Europe AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

10.6.4. Rest of Europe AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific AI In Oncology Market By Country

11.1. Asia Pacific AI In Oncology Market Overview

11.2. China

11.2.1. China AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

11.2.2. China AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

11.2.3. China AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

11.2.4. China AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

11.3. Japan

11.3.1. Japan AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

11.3.2. Japan AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

11.3.3. Japan AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

11.3.4. Japan AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

11.4. India

11.4.1. India AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

11.4.2. India AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

11.4.3. India AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

11.4.4. India AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

11.5. Australia

11.5.1. Australia AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

11.5.2. Australia AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

11.5.3. Australia AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

11.5.4. Australia AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

11.6. South Korea

11.6.1. South Korea AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

11.6.2. South Korea AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

11.6.3. South Korea AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

11.6.4. South Korea AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

11.7.2. Rest of Asia-Pacific AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

11.7.3. Rest of Asia-Pacific AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

11.7.4. Rest of Asia-Pacific AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America AI In Oncology Market By Country

12.1. Latin America AI In Oncology Market Overview

12.2. Brazil

12.2.1. Brazil AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

12.2.2. Brazil AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

12.2.3. Brazil AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

12.2.4. Brazil AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

12.3. Mexico

12.3.1. Mexico AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

12.3.2. Mexico AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

12.3.3. Mexico AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

12.3.4. Mexico AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

12.4.2. Rest of Latin America AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

12.4.3. Rest of Latin America AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

12.4.4. Rest of Latin America AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa AI In Oncology Market By Country 

13.1. Middle East & Africa AI In Oncology Market Overview

13.2. GCC

13.2.1. GCC AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

13.2.2. GCC AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

13.2.3. GCC AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

13.2.4. GCC AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

13.3. South Africa

13.3.1. South Africa AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

13.3.2. South Africa AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

13.3.3. South Africa AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

13.3.4. South Africa AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa AI In Oncology Revenue (USD Billion) and Forecast By Component, 2020-2032

13.4.2. Rest of Middle East & Africa AI In Oncology Revenue (USD Billion) and Forecast By Cancer Type, 2020-2032

13.4.3. Rest of Middle East & Africa AI In Oncology Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032

13.4.4. Rest of Middle East & Africa AI In Oncology Revenue (USD Billion) and Forecast By End-Users, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of AI In Oncology Market

14.1. AI In Oncology Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

14.2.2. New Product Launches and Product Enhancements

14.2.3. Mergers And Acquisition In Global AI In Oncology Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. IBM

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2022

15.1.3.2. IBM 2022 AI In Oncology Business Regional Distribution

15.1.4. Product/Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Siemens Healthineers

15.3. Azra AI

15.4. NVIDIA

15.5. GE Healthcare

15.6. Path AI

15.7. Intel

15.8. Concert.AI

15.9. Median Technologies

15.10. Digital Diagnostics Inc.